What are nirmatrelvir and ritonavir, and molnupiravir?
The nirmatrelvir and ritonavir combination and molnupiravir are oral antiviral medicines which can be used by patients with COVID-19 who have a high risk for developing severe disease, reducing the need for admission to hospital.3,4
- Therapeutic Goods Administration. Australian Product Information – Paxlovid® (nirmatrelvir/ritonavir tablets) Available from: https://www.tga.gov.au/resources/artg/377572 (accessed 30 April 2024)
- Therapeutic Goods Administration. Australian Product Information – Lagevrio® (molnupiravir capsules) Available from: https://www.tga.gov.au/resources/artg/372650 (accessed 30 April 2024).